You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 5,955,356


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,955,356
Title: Nucleic acids, vectors, and host cells including mycobacterium derived sequences
Abstract:The invention relates to nucleic acids which contain particularly a nucleotide sequence extending from the extremity constituted by the nucleotide at position (1) to the extremity constituted by the nucleotide at position (1211) represented on the figure, to the polypeptides coded by said nucleic acids. The polypeptides of the invention can be used for the diagnosis of tuberculosis, and can also be part of the active principle in the preparation of a vaccine against tuberculosis.
Inventor(s): Content; Jean (Rhode St-Genes, BE), De Wit; Lucas (Puurs, BE), De Bruyn; Jacqueline (Beersel, BE)
Assignee: N.V. Innogenetics S.A. (Ghent, BE)
Application Number:08/107,676
Patent Claims:1. An isolated nucleic acid segment comprising a nucleotide sequence selected from the group consisting of:

a nucleotide sequence comprising nucleotides from the nucleotide position (1) to the nucleotide position (149) in SEQ ID NO:2;

a nucleotide sequence coding for a polypeptide extending from the amino acid at position 1 to the amino acid at position 46 in SEQ ID NO: 3;

a nucleotide sequence coding for a polypeptide extending from the amino acid at position 26 to the amino acid at position 46 in SEQ ID NO:3;

a nucleotide sequence coding for peptide SQSNGQNY (SEQ ID NO:4);

a nucleotide sequence coding for peptide PMVQIPRLVA (SEQ ID NO:5);

a nucleotide sequence coding for peptide GLTRTNQTFRDTYAADGGRNG (SEQ ID NO:6);

a nucleotide sequence coding for peptide PPAAPAAPAA (SEQ ID NO:7); a nucleotide sequence fully complementary to the nucleotide sequences listed above; and a nucleotide sequence corresponding to the nucleotide sequences listed above in which nucleotide T is replaced by nucleotide U.

2. The isolated nucleic acid according to claim 1, comprising a nucleic acid coding for a peptide selected from the group consisting of:

a peptide extending from the amino acid at position 1 to the amino acid at position (-1) 46 in SEQ ID NO:3;

a peptide extending from the amino acid at position 26 to the amino acid at position 1 in SEQ ID NO:3;

a peptide extending from the amino acid at position 1 to the amino acid at position 340 in SEQ ID NO:3;

a peptide extending from the amino acid at position 26 to the amino acid at position 340 in SEQ ID NO:3; and

a peptide extending from the amino acid at 47 to the amino acid at position 340 in SEQ ID NO:3.

3. The isolated nucleic acid segment according to claim 1, encoding for a protein, wherein said protein:

reacts selectively with human sera from tuberculosis patients,

is recognized by antibodies which recognize the amino acid sequence extending from the amino acid at position 47 to the amino acid at position 340 in SEQ ID NO:3; or

generates antibodies which recognize the amino acid sequence extending from the amino acid at position position 47 to the amino acid at position 340 in SEQ ID NO:3.

4. The isolated nucleic acid segment according to claim 1 encoding for a mature protein of about 30 to about 35 kDa and containing a sequence for a signal peptide.

5. A recombinant vector comprising:

a vector sequence, wherein said vector sequence is selected from the group consisting of a plasmid, a cosmid, a phage DNA, and a virus DNA; and

a nucleic acid segment according to claim 1, inserted in one of the non-essential sites for replication of said vector sequence.

6. A recombinant vector comprising in one of its non-essential sites for replication elements necessary to promote the expression of the polypeptide or peptide encoded by the nucleic acid segment according to claim 1 in a cellular host and also a promoter recognized by the RNA polymerase of the cellular host.

7. The recombinant vector according to claim 5 comprising elements enabling expression by E. coli of the polypeptide or peptide.

8. A Mycobacterium bovis BCG vaccine strain transformed with the DNA segment according to claim 1, wherein said nucleic segment further comprises a nucleotide acid sequence encoding a foreign epitope.

9. An isolated host cell which is transformed by a recombinant vector according to claim 6.

10. The isolated host cell according to claim 9, wherein said isolated host cell is a prokaryote or an cukaryotic organism.

11. An isolated nucleic acid segment comprising a nucleotide sequence selected from the following nucleotide sequences:

a nucleotide sequence extending from the nucleotide at position (150) to the nucleotide at position (287) in SEQ ID NO:2;

a nucleotide sequence extending from the nucleotide at position (224) to the nucleotide at position (287) in SEQ ID NO:2;

a nucleotide sequence extending from the nucleotide at position (537) to the nucleotide at position (560) in SEQ ID NO:2;

a nucleotide sequence extending from the nucleotide at position (858) to the nucleotide at position (887) in SEQ ID NO:2;

a nucleotide sequence extending from the nucleotide at position (972) to the nucleotide at position (1037) in SEQ ID NO:2;

a nucleotide sequence extending from the nucleotide at position (1140) to the nucleotide at position (1169) in SEQ ID NO:2;

a nucleotide sequence fully complementary to the nucleotide sequences listed above; and

a nucleotide sequence corresponding to the nucleotide sequences listed above in which nucleotide T is replaced by nucleotide U.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.